UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
December 1, 2021
Accession Number:
0001104659-21-143413
Submission Type:
POS AM
CIK:
0001328143
Company Name:
Adamas Pharmaceuticals Inc
File Number:
333-234570